A5101863454- Neutropenia and Cancer Infections
- Effects of Radiation Exposure
- Blood disorders and treatments
- Chemotherapy-related skin toxicity
- TGF-β signaling in diseases
- Psoriasis: Treatment and Pathogenesis
- Pediatric Urology and Nephrology Studies
- Cancer-related molecular mechanisms research
- Melanoma and MAPK Pathways
- Complementary and Alternative Medicine Studies
- Pediatric Pain Management Techniques
- Health Systems, Economic Evaluations, Quality of Life
- Antibiotics Pharmacokinetics and Efficacy
- Antifungal resistance and susceptibility
- Connective Tissue Growth Factor Research
- Nonmelanoma Skin Cancer Studies
- RNA modifications and cancer
- Cutaneous lymphoproliferative disorders research
- Gastric Cancer Management and Outcomes
- Urological Disorders and Treatments
- Management of metastatic bone disease
- Bacterial Identification and Susceptibility Testing
- Cancer-related gene regulation
- Tuberculosis Research and Epidemiology
- Anesthesia and Pain Management
Sunnybrook Health Science Centre
2018-2022
Health Sciences Centre
2018-2022
University of Toronto
2022
Stanford University
2021
Saint Louis University
2019
University of Waterloo
2019
Albany Medical Center Hospital
2017
UW Health University Hospital
2016
University of Wisconsin–Madison
2015
Icahn School of Medicine at Mount Sinai
2004
Summary Candidaemia is the most common clinical presentation of invasive candidiasis and a major cause morbidity mortality. Candiduria predictor for candidaemia; however, patient characteristics that are associated with concurrent candidaemia in setting candiduria unclear. Identifying these could aid early detection systemic disease. We performed retrospective cohort analysis hospitalised patients at our institution over 13‐year period. Our evaluation included demographics, comorbidities,...
Abstract: The world of oncology treatment is rapidly changing, and with the investigation into utilization molecular signaling pathways for cancer treatment, many new targeted small-molecule oral agents have been introduced as therapies, more drugs appearing every year. These agents, while generally considered less toxic overall than traditional chemotherapy, are not without adverse effects. authors undertook an extensive literature search to determine incidence, severity, management...
Open-access (OA) colonoscopies are defined as those scheduled without a gastrointestinal (GI) office visit. Past research has not focused on split preparation use and patient perception within OA. We aim to identify differences in bowel (BP) adequacy, adenoma detection rate (ADR), self-reported compliance, between OA GI providers using prep.This was cross-sectional study BP for colonoscopies. Patients completed survey, demographics, ADR were recorded. compliance self-reported. asked three...
Introduction: Endovascular interventions are the first line treatment for patients with atherosclerotic disease. However, a significant number of these fail due to neointimal hyperplasia. The Wnt4/β-catenin pathway has been reported play an important role in this process, but mechanism underlying up-regulation after injury remains unclear. Our lab previously demonstrated that following vascular injury, elevated TGF-β and its signaling protein, Smad3, exacerbate intimal hyperplasia Smooth...
Febrile neutropenia (FN) is a common side effect of cytotoxic chemotherapy that may result in poor treatment outcomes. The short acting granulocyte colony stimulating factors (G-CSF) act to stimulate granulocytes increase production white blood cells. filgrastim biosimilar useful, as it provide cheaper and equally effective FN. This study explored the usage (Grastofil®) reference biologic (Neupogen®) breast cancer lymphoma patients. A retrospective chart review patients receiving Grastofil®...
v Grastofil® (filgrasEm) is a biosimilar to the reference biologic drug Neupogen® 1 .EffecEve December 22, 2016, Ontario Drug Benefit (ODB) Program began funding for prevenEon and treatment of neutropenia associated with chemotherapy .